Tuberculosis unleashed: The impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis

Microbes and Infection

Volumn 4, Issue 6, 2002, Pages 635-646

  Lawn, Stephen D ^a   Butera, Salvatore T ^b   Shinnick, Thomas M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cell mediated immunity; Granuloma; Human immunodeficiency virus type 1; Mycobacterium tuberculosis; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 2; PENTOXIFYLLINE; THALIDOMIDE; TUBERCULOSTATIC AGENT;

CELL FUNCTION; CHEMOPROPHYLAXIS; CLINICAL FEATURE; DISEASE COURSE; GRANULOMA; GRANULOMATOSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; INCIDENCE; INFECTION RISK; LATENT PERIOD; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; T LYMPHOCYTE; TUBERCULOSIS;

CD4-POSITIVE T-LYMPHOCYTES; GRANULOMA, RESPIRATORY TRACT; HIV INFECTIONS; HIV-1; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0036274370     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01582-4     Document Type: Article

References (92)

1. The role of T-cell subsets in Mycobacterium tuberculosis infection
2. The granulomatous inflammatory response
3. Contacts of cases of active pulmonary tuberculosis
4. Infectivity of pulmonary tuberculosis in relation to sputum status
5. Immune mechanisms in the pathogenesis of pulmonary tuberculosis
6. Cytokine/chemokine cascades in immunity to tuberculosis
7. Restraining mycobacteria: Role of granulomas in mycobacterial infections
8. Mechanisms of latency in Mycobacterium tuberculosis
9. Effect of preventive treatment for tuberculosis in adults infected with HIV: Systematic review of randomised placebo controlled trials
10. Nosocomial epidemic of active tuberculosis among HIV-infected patients
11. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients
12. Tuberculosis outbreak among persons in a residential facility for HIV-infected persons, Florida and New York
13. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection
14. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms
15. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection
16. A retrospective cohort study of the risk of tuberculosis among women of childbearing age in Zaire
17. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia
18. Tuberculosis and HIV infection in sub-Saharan Africa
19. Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi
20. Pulmonary tuberculosis: Radiological differences in West Africans coinfected with HIV
21. The mortality and pathology of HIV infection in a west African city
22. Pathogenesis of tuberculosis in human immunodeficiency virus-infected people
23. Autopsy findings in 70 AIDS patients who died in a department of pneumonology in Ivory Coast: Impact of tuberculosis
24. Tuberculosis in HIV-positive patients: Cellular response and immune activation in the lung
25. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote D'Ivoire
26. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis
27. Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins on monocytes phagocytic function, oxidative burst, transendothelial migration, and cell surface phenotype
28. HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes
29. Macrophages from human immunodeficiency virus-positive persons are defective in host defense against Histoplasma capsulatum
30. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation
31. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans
32. HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii
33. Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo
34. Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection
35. Modulation of antigen-presenting capacity of human monocytes by HIV-1 gp120 molecule fragments
36. Human immunodeficiency virus type 1 infection of alveolar macrophages impairs their innate fungicidal activity
37. Human immunodeficiency virus causes mononuclear phagocyte dysfunction
38. Increased Mycobacterium tuberculosis growth in HIV-1-infected human macrophages: Role of tumour necrosis factor-alpha
39. Human immunodeficiency virus type 1 enhances intracellular growth of Mycobacterium avium in human macrophages
40. HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines
41. T cell dynamics in HIV-1 infection
42. Phagocytosis of M. tuberculosis modulates human immunodeficiency virus replication in human monocytic cells
43. Mycobacterium tuberculosis and its purified protein derivative activate expression of human immunodeficiency virus
44. Mycobacterium tuberculosis enhances HIV-1 replication by transcriptional activation at the long terminal repeat
45. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
46. Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients
47. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals
48. Infection by Mycobacterium tuberculosis promotes alveolar macrophage apoptosis
49. Generalised immune activation in pulmonary tuberculosis: Coactivation with HIV infection
50. Sustained plasma TNF-α and HIV-1 load despite resolution of other immune activation parameters during treatment for tuberculosis in Africans
51. Tuberculosis HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and βmicroglobulin, respectively
52. Augmentation of apoptosis and interferon-γ production at sites of active Mycobacterium tuberculosis infection in human tuberculosis
53. HIV-induced deletion of antigen-specific T cell function is MHC restricted
54. Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation
55. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection
56. A.S. Fauci, Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome
57. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency seropositive patients
58. The immunopathogenesis of HIV infection
59. Human immunodeficiency virus type 1 envelope glycoprotein gp 120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA
60. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV
61. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection
62. Constitutive expression of human immunodeficiency virus type 1 tat gene inhibits interleukin 2 and interleukin 2 receptor expression in a human CD4+ T lymphoid line
63. Lack of induction of interleukin-2-receptor alpha expression in patients with tuberculosis and human immunodeficiency virus coinfection: Implications for pathogenesis
64. Interleukin 12 at the site of disease in tuberculosis
65. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria
66. Type 1/type 2 immunity in infectious diseases
67. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression
68. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection
69. Inhibition of IL-12 production in human monocyte-derived macrophages by TNF
70. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection
71. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage
72. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung
73. Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection
74. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
75. Macrophages as a source of HIV during opportunistic infections
76. Cellular compartments of HIV-1 replication: Determination by virion-associated host proteins and the impact of opportunistic infection in vivo
77. The acquisition of host-encoded proteins by nascent HIV-1
78. Incorporation of HLA-DR into the HIV-1 envelope: Correlation with stage of disease and the effect of opportunistic infection in vivo
79. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity
80. Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1
81. Greater diversity of HIV-1 quasispecies in HIV-infected individuals with active tuberculosis
82. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire
83. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS Clinical Trials Group Protocol 315
84. Restoration of normal interleukin-2 production by CD4+ T cells of human immunodeficiency virus-infected patients after 9 months of highly active antiretroviral therapy
85. Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients
86. HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The adult/adolescent spectrum of HIV disease group
87. HAART in HIV-infected patients: Restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia
88. Immune mediated `HAART' attack during treatment for tuberculosis. Highly active antiretroviral therapy
89. Cytokine therapy of mycobacterial infections